Latest News from: La Jolla Institute for Immunology

Add to Favorites Subscribe Share
newswise-fb-share-
Press "esc" to clear
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 101
GerminalCenter.png
  • Embargo expired:
    6-Feb-2019 2:00 PM EST

Article ID: 707398

Why your kid’s strep throat keeps coming back

La Jolla Institute for Immunology

Each year, some 600 million people around the world come down with strep throat. Yet, it was unclear why some kids are prone to repeated bouts of strep throat while others appear to be more or less immune. The latest study by researchers at La Jolla Institute for Immunology (LJI) provides the first clues why some children are more susceptible than others to contracting recurrent strep throat.

Released:
4-Feb-2019 7:00 AM EST
Sette_Peters_IEDB.png

Article ID: 706971

La Jolla Institute Awarded Renewal of NIH Contract to Continue Its Role as Host of Immune Epitope Database

La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) has been awarded a $22 million contract renewal over seven years from the National Institutes of Health (NIH) to host and expand the Immune Epitope Database (IEDB). The database is the world’s most comprehensive collection of scientific data on how the immune system responds to a wide range of infectious agents, allergy-causing substances, and other stimuli that activate the immune system.

Released:
23-Jan-2019 4:05 PM EST
LJIExterior2016-08-1901.jpg

Article ID: 705654

La Jolla Institute for Immunology renews longtime collaboration with Kyowa Kirin Pharmaceutical Research, Inc.

La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) and Kyowa Kirin Pharmaceutical Research, Inc. (KKR), a wholly-owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (KHK), a global specialty pharmaceutical company, today announced the signing of a new agreement. The agreement extends the longest industry-academic collaboration in the world for another three-year term, through until the end of 2021.

Released:
18-Dec-2018 5:05 PM EST
2018Dr.MatthiasvonHerrath.jpg

Article ID: 705327

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

La Jolla Institute for Immunology

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and easily find the best clinicians or pioneering scientists specializing in a wide range of medical conditions or biomedical topics.

Released:
12-Dec-2018 11:05 AM EST
2018 LJI rebrand COLOR copy.png
  • Embargo expired:
    15-Nov-2018 11:00 AM EST

Article ID: 703806

DICE: Immune cell atlas goes live

La Jolla Institute for Immunology

For more than four years, a team of LJI scientists led by Associate Professor Pandurangan Vijayanand, M.D., Ph.D., has been undertaking a massive immunoprofiling effort, detailing how variations in DNA sequence impact gene activity in different types of immune cells.

Released:
12-Nov-2018 12:05 PM EST
10a14883-a0df-4487-9122-da86be1a04ce.JPG
  • Embargo expired:
    14-Nov-2018 11:00 AM EST

Article ID: 703686

Maternally-Acquired Zika Immunity Can Increase Dengue Disease Severity in Mouse Pups

La Jolla Institute for Immunology

In this study, La Jolla Institute for Immunology (LJI) investigator Sujan Shresta, Ph.D., who studies both dengue and Zika viruses, explored awhether maternal immunity to Zika virus, which is structurally and genetically similar to dengue, might trigger a severe response to dengue infection in offspring.

Released:
8-Nov-2018 5:05 PM EST
Tlymphocyte.png

Article ID: 703903

Global immunoprofiling effort reveals multifunctional T cell response during Zika infection

La Jolla Institute for Immunology

The latest study by researchers at the La Jolla Institute for Immunology (LJI) and their collaborators provide the first in-depth characterization of the body’s cytotoxic T cell response to Zika, which plays an important role in providing protective immunity against Zika.

Released:
13-Nov-2018 11:05 AM EST
STIMstructure.png
  • Embargo expired:
    31-Oct-2018 5:00 AM EDT

Article ID: 702886

LJI investigators discover how protein pair controls cellular calcium signals

La Jolla Institute for Immunology

Two studies recently published by La Jolla Institute for Immunology (LJI) investigators Patrick Hogan, PhD, and Aparna Gudlur, PhD, report how a calcium-sensing protein called STIM1 signals that it's time to initiate calcium retrieval and then relays that message to its partner, the calcium channel ORAI.

Released:
26-Oct-2018 1:35 PM EDT
untitled-1654-Edit.jpg

Article ID: 702437

La Jolla Institute Receives $ 4.5 Mill Cancer Moonshot Award

La Jolla Institute for Immunology

Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million as part of the National Cancer Institute’s Cancer Moonshot initiative. The funding will support research to develop new and improved immunotherapeutic treatment options for patients with head and neck cancer.

Released:
18-Oct-2018 1:05 PM EDT
Neutrophils_bl.png
  • Embargo expired:
    28-Aug-2018 11:00 AM EDT

Article ID: 699440

Researchers Find Elusive Source of Most Abundant Immune Cell

La Jolla Institute for Immunology

Neutrophils—short-lived, highly mobile and versatile—outnumber all other immune cells circulating through the blood stream. Now, researchers at La Jolla Institute for Allergy and Immunology identified a progenitor of neutrophils in the bone marrow of mice and humans and tied it to cancer-promoting activities.

Released:
24-Aug-2018 11:35 AM EDT

Showing results

110 of 101

Chat now!